EVON MEDICS LLC

Elkridge, MD · Medtech · Private

Portable digital device for automated chemosensory and sensorimotor testing to stage cognitive decline and predict Alzheimer's disease progression

Grants
$19M
24 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
1 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
Federal grantDepartment of Health and Human Services · Phase I · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$450,000
Federal grantDepartment of Health and Human Services · Phase I · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
Federal grantDepartment of Health and Human Services · Phase I · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for relapse preventionin patients with Opioid Use (OUD)$225,000
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder$820,883
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,247,784
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease$2,641,180
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder$859,103
Federal grantDepartment of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$330,680
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,245,116
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$50,000
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease$98,280
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$499,999
Federal grantDepartment of Health and Human Services · Phase I · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$499,999
Federal grantDepartment of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$55,000
Federal grantDepartment of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,318,829
Federal grantDepartment of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,318,829
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$448,887
Federal grantDepartment of Health and Human Services · Phase I · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$448,887
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$1,349,130
Federal grantDepartment of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,219,088
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$1,249,244
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$1,280,870
Federal grantDepartment of Health and Human Services · Phase II · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$1,249,244
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
953SOMAVAC Medical Solutions, Inc.—$13M
954Surgimatix, Inc.—$1.4M
955Advion, Inc.—$6.5M
956EVON MEDICS LLC——
957WHITE EAGLE SONIC TECHNOLOGIES, INC.—$2.8M
958JB HEALTHTECH, INC.——
959MNT SMARTSOLUTIONS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 5
  • Olfactory Testing Systems And Methodsgranted
  • Pain Treatment Apparatus and Methodsapplication
  • Pain Treatment Apparatus And Methodsapplication
  • Olfactory Testing Systems And Methodsapplication
  • Olfactory Testing Systems And Methodsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.